673 related articles for article (PubMed ID: 30177023)
1. Murine Models of Human IgA Nephropathy.
Suzuki H; Suzuki Y
Semin Nephrol; 2018 Sep; 38(5):513-520. PubMed ID: 30177023
[TBL] [Abstract][Full Text] [Related]
2. Development of Animal Models of Human IgA Nephropathy.
Suzuki H; Suzuki Y; Novak J; Tomino Y
Drug Discov Today Dis Models; 2014; 11():5-11. PubMed ID: 25722731
[TBL] [Abstract][Full Text] [Related]
3. Gluten exacerbates IgA nephropathy in humanized mice through gliadin-CD89 interaction.
Papista C; Lechner S; Ben Mkaddem S; LeStang MB; Abbad L; Bex-Coudrat J; Pillebout E; Chemouny JM; Jablonski M; Flamant M; Daugas E; Vrtovsnik F; Yiangou M; Berthelot L; Monteiro RC
Kidney Int; 2015 Aug; 88(2):276-85. PubMed ID: 25807036
[TBL] [Abstract][Full Text] [Related]
4. Fcalpha receptor (CD89) mediates the development of immunoglobulin A (IgA) nephropathy (Berger's disease). Evidence for pathogenic soluble receptor-Iga complexes in patients and CD89 transgenic mice.
Launay P; Grossetête B; Arcos-Fajardo M; Gaudin E; Torres SP; Beaudoin L; Patey-Mariaud de Serre N; Lehuen A; Monteiro RC
J Exp Med; 2000 Jun; 191(11):1999-2009. PubMed ID: 10839814
[TBL] [Abstract][Full Text] [Related]
5. Critical Role of Kupffer Cell CD89 Expression in Experimental IgA Nephropathy.
Xu L; Li B; Huang M; Xie K; Li D; Li Y; Gu H; Fang J
PLoS One; 2016; 11(7):e0159426. PubMed ID: 27437939
[TBL] [Abstract][Full Text] [Related]
6. Both IgA nephropathy and alcoholic cirrhosis feature abnormally glycosylated IgA1 and soluble CD89-IgA and IgG-IgA complexes: common mechanisms for distinct diseases.
Tissandié E; Morelle W; Berthelot L; Vrtovsnik F; Daugas E; Walker F; Lebrec D; Trawalé JM; Francoz C; Durand F; Moura IC; Paradis V; Moreau R; Monteiro RC
Kidney Int; 2011 Dec; 80(12):1352-63. PubMed ID: 21866091
[TBL] [Abstract][Full Text] [Related]
7. Role of IgA receptors in the pathogenesis of IgA nephropathy.
Lechner SM; Papista C; Chemouny JM; Berthelot L; Monteiro RC
J Nephrol; 2016 Feb; 29(1):5-11. PubMed ID: 26572664
[TBL] [Abstract][Full Text] [Related]
8. Soluble CD89 is a critical factor for mesangial proliferation in childhood IgA nephropathy.
Cambier A; Gleeson PJ; Abbad L; Canesi F; da Silva J; Bex-Coudrat J; Deschênes G; Boyer O; Rabant M; Ulinski T; Hogan J; Peuchmaur M; Berthelot L; Monteiro RC
Kidney Int; 2022 Feb; 101(2):274-287. PubMed ID: 34756952
[TBL] [Abstract][Full Text] [Related]
9. IgA1 Protease Treatment Reverses Mesangial Deposits and Hematuria in a Model of IgA Nephropathy.
Lechner SM; Abbad L; Boedec E; Papista C; Le Stang MB; Moal C; Maillard J; Jamin A; Bex-Coudrat J; Wang Y; Li A; Martini PG; Monteiro RC; Berthelot L
J Am Soc Nephrol; 2016 Sep; 27(9):2622-9. PubMed ID: 26850635
[TBL] [Abstract][Full Text] [Related]
10. Fecal Microbiota Transplantation Modulates Renal Phenotype in the Humanized Mouse Model of IgA Nephropathy.
Lauriero G; Abbad L; Vacca M; Celano G; Chemouny JM; Calasso M; Berthelot L; Gesualdo L; De Angelis M; Monteiro RC
Front Immunol; 2021; 12():694787. PubMed ID: 34712223
[TBL] [Abstract][Full Text] [Related]
11. Mesangial Deposition Can Strongly Involve Innate-Like IgA Molecules Lacking Affinity Maturation.
Wehbi B; Oblet C; Boyer F; Huard A; Druilhe A; Paraf F; Cogné E; Moreau J; El Makhour Y; Badran B; Van Egmond M; Cogné M; Aldigier JC
J Am Soc Nephrol; 2019 Jul; 30(7):1238-1249. PubMed ID: 31227634
[TBL] [Abstract][Full Text] [Related]
12. IgA nephropathy and Henoch-Schoenlein purpura nephritis: aberrant glycosylation of IgA1, formation of IgA1-containing immune complexes, and activation of mesangial cells.
Novak J; Moldoveanu Z; Renfrow MB; Yanagihara T; Suzuki H; Raska M; Hall S; Brown R; Huang WQ; Goepfert A; Kilian M; Poulsen K; Tomana M; Wyatt RJ; Julian BA; Mestecky J
Contrib Nephrol; 2007; 157():134-8. PubMed ID: 17495451
[TBL] [Abstract][Full Text] [Related]
13. A Proliferation Inducing Ligand (APRIL) targeted antibody is a safe and effective treatment of murine IgA nephropathy.
Myette JR; Kano T; Suzuki H; Sloan SE; Szretter KJ; Ramakrishnan B; Adari H; Deotale KD; Engler F; Shriver Z; Wollacott AM; Suzuki Y; Pereira BJG
Kidney Int; 2019 Jul; 96(1):104-116. PubMed ID: 31027890
[TBL] [Abstract][Full Text] [Related]
14. Sparsentan ameliorates glomerular hypercellularity and inflammatory-gene networks induced by IgA1-IgG immune complexes in a mouse model of IgA nephropathy.
Reily C; Moldoveanu Z; Pramparo T; Hall S; Huang ZQ; Rice T; Novak L; Komers R; Jenkinson CP; Novak J
Am J Physiol Renal Physiol; 2024 May; 326(5):F862-F875. PubMed ID: 38511222
[TBL] [Abstract][Full Text] [Related]
15. Recurrent IgA nephropathy is predicted by altered glycosylated IgA, autoantibodies and soluble CD89 complexes.
Berthelot L; Robert T; Vuiblet V; Tabary T; Braconnier A; Dramé M; Toupance O; Rieu P; Monteiro RC; Touré F
Kidney Int; 2015 Oct; 88(4):815-22. PubMed ID: 26061544
[TBL] [Abstract][Full Text] [Related]
16. Experimental IgA-IgG nephropathy induced by a viral respiratory pathogen. Dependence on antigen form and immune status.
Jessen RH; Emancipator SN; Jacobs GH; Nedrud JG
Lab Invest; 1992 Sep; 67(3):379-86. PubMed ID: 1328763
[TBL] [Abstract][Full Text] [Related]
17. LPS/TLR4 Pathway Regulates IgA1 Secretion to Induce IgA Nephropathy.
He H; Shen M; Tang Y; Sun W; Xu X
Altern Ther Health Med; 2024 Jan; 30(1):419-425. PubMed ID: 37820669
[TBL] [Abstract][Full Text] [Related]
18. Immunostaining of galactose-deficient IgA1 by KM55 is not specific for immunoglobulin A nephropathy.
Zhao L; Peng L; Yang D; Chen S; Lan Z; Zhu X; Yuan S; Chen G; Liu Y; Liu H
Clin Immunol; 2020 Aug; 217():108483. PubMed ID: 32479989
[TBL] [Abstract][Full Text] [Related]
19. TLR9 activation induces aberrant IgA glycosylation via APRIL- and IL-6-mediated pathways in IgA nephropathy.
Makita Y; Suzuki H; Kano T; Takahata A; Julian BA; Novak J; Suzuki Y
Kidney Int; 2020 Feb; 97(2):340-349. PubMed ID: 31748116
[TBL] [Abstract][Full Text] [Related]
20. New insights in the pathogenesis of IgA nephropathy.
Monteiro RC
Nefrologia; 2005; 25 Suppl 2():82-6. PubMed ID: 16050408
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
